• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS ESHEATH INTRODUCER SET; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS ESHEATH INTRODUCER SET; INTRODUCER, CATHETER Back to Search Results
Model Number 9610ES14
Device Problems Peeled/Delaminated (1454); Material Puncture/Hole (1504); Material Integrity Problem (2978); Physical Resistance/Sticking (4012)
Patient Problem Insufficient Information (4580)
Event Date 11/30/2022
Event Type  malfunction  
Manufacturer Narrative
The investigation is ongoing.The device has not been returned.
 
Event Description
As reported, it was a case of an implant of a 26mm sapien 3 ultra transcatheter heart valve, in aortic position by transfemoral approach.During procedure, resistance was felt while advancing the delivery system through the esheath.Greater force was exerted to advance up towards the common iliac.It was observed in fluoro that the esheath was split and the delivery system exited the esheath.It was not possible to retrieve the valve fully back into the esheath or advance it.It was decided to further split the esheath to allow the valve to came out of the esheath.Due to the resistance, the valve looked a bit lopsided, slightly off position.It was decided to implant the valve as it was thought to be not damaged.The valve was deployed successfully.Then, the delivery system and the esheath were removed separately without resistance.Patient is recovering well.No patient injury.Based on the imagery provided, the sheath had split and liner strand was noted.There were no missing pieces.A per medical opinion, the vascular anatomy and calcification was responsible for the sheath split as friction felt on advancement.
 
Manufacturer Narrative
A supplemental mdr is being submitted for additional information.Additional device code was added based on preliminary decontamination.The investigation is ongoing.
 
Manufacturer Narrative
The device was returned to edwards lifesciences for evaluation and the following was observed.Sheath shaft curvature.Liner torn for 16cm in length starting from distal tip.Three liner strands present along the liner tear each with length of 5cm, 1.5cm, and 0.5cm, respectively.Distal tip opened as designed but soft tip was damaged.Hdpe stretching and scratches along length of shaft.Imagery was provided from the site and revealed the following: post-procedural device photo showed sheath shaft is curved, introducer is exposed through torn liner, and liner strands are present.Fluoroscopy videos showed delivery system and crimped valve appear to be located outside the sheath shaft, suggesting a torn sheath liner.Delivery system and crimped valve shown before and after ''jumping, after greater force exerted''.3mensio showed calcification is present along the iliac and tortuosity is also present along the iliac with adequately sized vessel diameters.During manufacturing, the device undergoes multiple inspections.In addition, the work order underwent functional product verification testing as a requirement for lot release.These inspections and tests during the manufacturing process support that it is unlikely that a non-conformance contributed to the reported complaint.The complaints were confirmed through evaluation of the returned device and procedural imagery.However, no manufacturing non-conformances were identified during evaluation of the complaint device.Reviews of the dhr, lot history, and complaint history did not provide any indication that a manufacturing non-conformance would have contributed to the complaint.A review of manufacturing mitigations supports that the sheath has proper inspections in place to detect issues related to the complaint event.A review of ifu/training materials revealed no deficiencies.Furthermore, there was no report of any issue with the sheath during device unpacking or preparation.In this case, ''during procedure, resistance was felt while advancing the delivery system through the esheath.Greater force was exerted to advance up towards the common iliac.It was observed in fluoro that the esheath was split and the delivery system exited the esheath.It was not possible to retrieve the valve fully back into the esheath or advance it.It was decided to further split the esheath to allow the valve to came out of the esheath.Due to the resistance, the valve looked a bit lopsided, slightly off position.It was decided to implant the valve as it was thought to be not damaged.The valve was deployed successfully.Then, the delivery system and the esheath were removed separately without resistance.Patient is recovering well.No patient injury.Based on the imagery provided, the sheath had split and liner strand was noted.There were no missing pieces.A per medical opinion, the vascular anatomy and calcification was responsible for the sheath split as friction felt on advancement.Difficulty advancing and distal tip damage: per review of returned imagery, the delivery system and crimped valve appear to be located outside the sheath shaft and appear to ''jump'' after greater force was exerted, as reported.The sheath shaft was also curved, the introducer exposed through the torn liner, and liner strands were present.Lastly, calcification, tortuosity, and adequately sized vessel diameters are present along the access vessel.Per visual inspection of the returned device, sheath shaft curvature was observed.The liner was torn for 16cm from the distal tip.Three liner strands were observed along the torn liner: 5cm, 1.5cm, and 0.5cm in length.The sheath distal tip was opened as designed and had soft tip damage.In addition, there was stretching and scratches on the sheath shaft.Per the training manual, ''push force can vary due to angle of insertion, thv size, vessel diameter, tortuosity, and degree of calcification.If push force is too high or valve and sheath are damaged or valve is still stuck, remove valve and sheath together as a single unit and replace, and do not over-manipulate the sheath at any time.'' calcification can reduce the vessel diameter and may increase restriction leading to resistance.Calcification can also damage the outer sheath and sheath liner, potentially contributing to the observed distal tip and liner damage.Tortuous vessels can create sub-optimal angles that can lead to non-axial alignment in the advancement of the delivery system and further contribute to the reported resistance and observed sheath damage.In addition, if excessive manipulation and high push force were used to overcome the resistance, this may have further contributed to the sheath damage observed.Lastly, as the delivery system and crimped valve were outside of the sheath through the torn liner during advancement, this may have further damaged the distal tip and created the liner strands as it was continued to be advanced.Liner punctured: an existing technical summary written by edwards lifesciences has been documented for root cause analysis on sheath shaft liner tears with normal liner expansion.In this technical summary, a review of liner tear complaint investigations on returned devices over a two-year period found that patient / procedural factors (e.G.Access vessel tortuosity / calcification or withdrawal of a burst or torn balloon) are likely the contributing factors for sheath shaft liner tears.Per evaluation of the returned device, the sheath liner was torn for 16cm in length starting from distal tip.Review of imagery shows calcification and tortuosity within the access vessel.Calcification can damage the exposed portion of the sheath liner.Damage along the liner could lead to immediate cutting/tearing or could weaken the liner.A weakened liner can tear during advancement or retrieval of the delivery system.Vessel angulation can create suboptimal angles during delivery system advancement through the sheath.The delivery system or balloon catheter can potentially catch on to liner of the sheath and lead to liner tears upon removal.The technical summary demonstrated that there were no deficiencies in the ifu/training manuals and outlines the extensive manufacturing mitigations in place to detect a defect or nonconformance associated with sheath shaft liner tears.There are several 100% in-process inspections (visual) performed in manufacturing process and product verification testing (functional and visual) on a sampling plan basis performed prior to lot release.It should be noted that these mitigations (from manufacturing and the ifu/training manual), as identified in the technical summary, are still in place.As such, these inspections and testing support that it is unlikely that a manufacturing non-conformance contributed to the complaint.As such, available information suggests that patient factors (calcification, tortuosity) and/or procedural factors (excessive manipulation) may have contributed to the complaint events.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.No ifu/labeling/training manual inadequacies were identified.A product risk assessment (pra) was previously initiated and to address the issue and no corrective or preventative action assessment is required at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS ESHEATH INTRODUCER SET
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key16011757
MDR Text Key306247501
Report Number2015691-2022-10160
Device Sequence Number1
Product Code DYB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K200258
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 02/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9610ES14
Device Lot Number64466495
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/30/2022
Initial Date FDA Received12/20/2022
Supplement Dates Manufacturer Received01/09/2023
02/24/2023
Supplement Dates FDA Received01/09/2023
02/27/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/30/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age84 YR
-
-